P450 Oxidoreductase Deficiency
- 1 December 2005
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1061 (1), 100-108
- https://doi.org/10.1196/annals.1336.012
Abstract
Microsomal P450 enzymes, which metabolize drugs and catalyze steroid biosynthesis require electron donation from NADPH via P450 oxidoreductase (POR). POR knockout mice are embryonically lethal, but we found recessive human POR missense mutations causing disordered steroidogenesis and Antley-Bixler syndrome (ABS), a skeletal malformation syndrome featuring craniosynostosis. Dominant mutations in exons 8 and 10 of fibroblast growth factor receptor 2 (FGFR2) cause phenotypically related craniosynostosis syndromes and were reported in patients with ABS and normal steroidogenesis. Sequencing POR and FGFR2 exons in 32 patients with ABS and/or hormonal findings suggesting POR deficiency showed complete genetic segregation of POR and FGFR2 mutations. Fifteen patients carried POR mutations on both alleles, four carried POR mutations on 1 allele, nine carried FGFR2/3 mutations on one allele and no mutation was found in three patients. The 34 affected POR alleles included 10 with A287P, 7 with R457H, 9 other missense mutations and 7 frameshifts. These 11 missense mutations and 10 others identified by database mining were expressed in E. coli, purified to apparent homogeneity, and their catalytic capacities were measured in four assays: reduction of cytochrome c, oxidation of NADPH, and support of the 17alpha-hydroxylase and 17,20 lyase activities of human P450c17. As assessed by Vmax/Km, 17,20 lyase activity provided the best correlation with clinical findings. Modeling human POR on the X-ray crystal structure of rat POR shows that these mutant activities correlate well with their locations in the structure. POR deficiency is a new disease, distinct from the craniosynostosis syndromes caused by FGFR mutationsKeywords
This publication has 44 references indexed in Scilit:
- P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestationsTrends in Endocrinology & Metabolism, 2004
- Transgenic Mice with a Hypomorphic NADPH-Cytochrome P450 Reductase Gene: Effects on Development, Reproduction, and Microsomal Cytochrome P450Journal of Pharmacology and Experimental Therapeutics, 2004
- Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley–Bixler syndromeAmerican Journal of Medical Genetics Part A, 2004
- Conditional knockout of the mouse NADPH-cytochrome p450 reductase genegenesis, 2003
- Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17Published by Elsevier BV ,2003
- Electrostatic Interaction between Cytochrome P450 and NADPH-P450 Reductase: Comparison of Mixed and Fused Systems Consisting of Rat Cytochrome P450 1A1 and Yeast NADPH-P450 ReductaseBiochemical and Biophysical Research Communications, 1999
- Glu-320 and Asp-323 Are Determinants of the CYP4A1 Hydroxylation Regiospecificity and Resistance to Inactivation by 1-AminobenzotriazoleBiochemistry, 1998
- Antley-Bixler syndromeClinical Dysmorphology, 1997
- Congenital Adrenal HyperplasiaNew England Journal of Medicine, 1986
- Male Pseudohermaphroditism Due to Multiple Defects in Steroid-Biosynthetic Microsomal Mixed-Function OxidasesNew England Journal of Medicine, 1985